1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome 2022 Dini et al

Discussion in 'Long Covid research' started by Andy, Dec 16, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    21,940
    Location:
    Hampshire, UK
    Highlights
    • Acute pericarditis is an important manifestation of long COVID-19 syndrome.
    • Thickened and bright pericardial layers with small effusions was the most frequent finding.
    • History of autoimmune and allergic disorders, and palpitations/arrhythmias were risk factors.
    Abstract

    Background
    The long COVID-19 syndrome has been recently described and some reports have suggested that acute pericarditis represents important manifestation of long COVID-19 syndrome. The aim of this study was to identify the prevalence and clinical characteristics of patients with long COVID-19, presenting with acute pericarditis.

    Methods
    We retrospectively included 180 patients (median age 47 years, 62% female) previously diagnosed with COVID-19, exhibiting persistence or new-onset symptoms ≥12 weeks from a negative naso-pharyngeal SARS CoV2 swamp test. The original diagnosis of COVID-19 infection was determined by a positive swab. All patients had undergone a thorough physical examination. Patients with suspected heart involvement were referred to a complete cardiovascular evaluation. Echocardiography was performed based on clinical need and diagnosis of acute pericarditis was achieved according to current guidelines.

    Results
    Among the study population, shortness of breath/fatigue was reported in 52%, chest pain/discomfort in 34% and heart palpitations/arrhythmias in 37%. Diagnosis of acute pericarditis was made in 39 patients (22%). Mild-to-moderate pericardial effusion was reported in 12, while thickened and bright pericardial layers with small effusions (< 5 mm) with or without comet tails arising from the pericardium (pericardial B-lines) in 27. Heart palpitations/arrhythmias (OR:3.748, p = 0.0030), and autoimmune disease and allergic disorders (OR:4.147, p = 0.0073) were independently related to the diagnosis of acute pericarditis, with a borderline contribution of less likelihood of hospitalization during COVID-19 (OR: 0.100, p = 0.0512).

    Conclusion
    Our findings suggest a high prevalence of acute pericarditis in patients with long COVID-19 syndrome. Autoimmune and allergic disorders, and palpitations/arrhythmias were frequently associated with pericardial disease.

    Open access, https://www.internationaljournalofcardiology.com/article/S0167-5273(22)01891-5/fulltext
     
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,437
    Location:
    Aotearoa New Zealand
    I was curious about use of the term acute pericarditis given that this was being diagnosed in patients with established LC and, I assumed, not necessarily short / self-limiting.

    The ESC guidelines are published as: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC).

     
    rvallee, alktipping and Trish like this.
  3. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,437
    Location:
    Aotearoa New Zealand
    Some snippets from the discussion —

     
    alktipping and Trish like this.

Share This Page